Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00078975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy
ClinicalTrials.gov study NCT01343121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma
ClinicalTrials.gov study NCT03810976. IPD Sharing: NO. Countries: 1. Publications: 0.
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)
ClinicalTrials.gov study NCT05410197. IPD Sharing: NO. Countries: 1. Publications: 0.
Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen
ClinicalTrials.gov study NCT00417209. IPD Sharing: Not stated. Countries: 21. Publications: 0.
Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11
ClinicalTrials.gov study NCT06440187. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
ClinicalTrials.gov study NCT00079352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT07259317. IPD Sharing: NO. Countries: 1. Publications: 0.
Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
ClinicalTrials.gov study NCT00212069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure
ClinicalTrials.gov study NCT01219192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alimta and Gemcitabine in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00434135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma
ClinicalTrials.gov study NCT00191503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen
ClinicalTrials.gov study NCT00602745. IPD Sharing: Not stated. Countries: 17. Publications: 0.
Adjuvant Effect of Chloroquine on Gemcitabine
ClinicalTrials.gov study NCT01777477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer
ClinicalTrials.gov study NCT00237575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma
ClinicalTrials.gov study NCT06749730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00234416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
ClinicalTrials.gov study NCT00564720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
ClinicalTrials.gov study NCT00987766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT01639885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.